Search

everythinglearnresearchcommunity

for

Search:↓

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Suppressing certain hormones might help prevent prostate cancer.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Castration and finasteride lower urinary oxalate in male rats, potentially treating urolithiasis.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Testicular microlithiasis may increase the risk of testicular cancer and patients with it should be closely monitored.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Estrogen therapy helped regrow hair in a bald man.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Finasteride reduces movement issues in Parkinson's disease rats.

Finasteride doesn't affect erections much, but may decrease libido in men.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.